AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021
Jan 29, 2021
30583_dirs_2021-01-28_9274b690-bab5-4558-96c8-7bafa1ad832f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-01-27
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-27 | Common Stock | M | 8333 | $26.49 | Acquired | 303885 | Direct |
| 2021-01-27 | Common Stock | S | 8333 | $85.49 | Disposed | 295552 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-27 | Stock Option (Right to buy Common Stock) | $26.49 | M | 8333 | Disposed | 2021-05-11 | Common Stock (8333) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 247533 | Indirect |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.
F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19